PriceTracker GLP-1

Wegovy alternatives: every cheaper route, ranked by what it costs

The cheapest alternative to Wegovy is compounded semaglutide: the same active ingredient, made by licensed pharmacies and sold through telehealth programs for a fraction of Novo Nordisk's price, and not FDA-approved. If you want an approved drug, the cheaper routes are Wegovy itself through NovoCare, the Wegovy pill, Lilly's self-pay Zepbound and the Foundayo pill. This guide prices each one from the maker's published terms and today's board.

9 min read · published October 2026

Studio still life: an unlabelled glass vial beside a short stack of three plain coins

Key takeaways

  • 1Cheapest overall: compounded semaglutide, Wegovy's own molecule, priced live below from every partner program we track. It is not FDA-approved.
  • 2Cheapest way to stay on Wegovy itself: NovoCare Pharmacy, $199 for each of the first two months for new self-pay patients, then $349 a month up to 2.4 mg.
  • 3No needles: the Wegovy pill from NovoCare, $149 a month at 1.5 mg, and Lilly's Foundayo from $149 a month at its lowest dose.
  • 4A stronger molecule: tirzepatide (Zepbound) lost more weight than semaglutide in the head-to-head trial, 20.2% against 13.7%. Lilly sells Zepbound self-pay from $299, and it is also sold compounded.
  • 5Ozempic is the same drug as Wegovy, labelled for type 2 diabetes, so it is an alternative mainly for people whose plan covers it for diabetes.

The cheapest alternative to Wegovy is Wegovy's own molecule, semaglutide, compounded by a licensed pharmacy and sold through a telehealth program. It costs a fraction of Novo Nordisk's price and it is not FDA-approved. Everything else on this page is an approved drug, and each one is cheaper than a pharmacy-priced Wegovy pen in a different way: a cheaper way to buy Wegovy itself, a pill, a different molecule, or a diabetes label your insurance may already pay for. Here is the floor today, read from every partner program we track:

Below, each alternative in the order most people look at them, with what it costs to stay on it, not just the first month.

The same molecule, compounded

Compounded semaglutide is the alternative most people who search this end up choosing, because it is the same active ingredient at a much lower monthly price. The trade is the approval. In FDA's words: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed."1 The pharmacy's state licence, not an FDA review of the finished product, is what stands behind the vial.

Every price below is read from the seller's own page, ranked cheapest first, with any membership fee counted in:

Before you pick one, read how compounded semaglutide compares with Wegovy and check the seller in ten minutes. A price gap this large attracts bad actors as well as good pharmacies.

First, the cheaper Wegovy

If the problem is the pharmacy price, the next alternative is Wegovy bought another way. Novo Nordisk sells it directly to people paying cash through NovoCare Pharmacy. New self-pay patients pay $199 for each of the first two months at 0.25 mg and 0.5 mg, then $349 a month for every pen dose up to 2.4 mg, and $399 for the 7.2 mg high dose.2 The two-month starter offer runs "through December 31, 2026", in Novo's words.

That is still $349 a month at the doses that do the work. The Wegovy cost guide prices the whole first year.

No needles: the Wegovy pill and Foundayo

Two weight-loss pills are now approved, and both are priced below the Wegovy pen at their starting doses.

The Wegovy pill is oral semaglutide, the same molecule as the pen. In Novo Nordisk's own words, "Wegovy is the first FDA-approved semaglutide pill for weight loss."3 NovoCare sells it to self-pay patients at $149 for each month of 1.5 mg, $199 for 4 mg and $299 for 9 mg and 25 mg.2 At every dose that is less than the $349 pen.

Foundayo is orforglipron, Lilly's pill. Lilly says "Individuals opting for self-pay can access Foundayo starting at $149 per month for the lowest dose." In the ATTAIN-1 trial, people on the highest dose who stayed on treatment lost 12.4% of their body weight, against 0.9% on placebo.7 That is a smaller average loss than the injections, in a different trial, so treat the comparison as rough.

Programs on our board that sell an oral GLP-1, cheapest first:

More in the Wegovy pill vs injection guide and the Foundayo vs Wegovy pill guide.

A stronger molecule: tirzepatide

Zepbound is Lilly's tirzepatide, approved for weight loss, and it is the approved alternative people compare Wegovy with most. The two drugs were tested against each other in SURMOUNT-5, a 72-week trial of 751 adults with obesity: tirzepatide reduced weight by 20.2% and semaglutide by 13.7%.4 If Wegovy is not working well enough, this is the alternative with the trial behind it.

It is not the cheaper one at the top doses. Lilly sells Zepbound to people paying cash at $299 for 2.5 mg and $399 for 5 mg, then $499 at 7.5 mg and $699 from 10 mg up.5 For the KwikPen there is one more Lilly price: $449 a month from 7.5 mg up, kept only if "you must complete your refill purchase of the Zepbound single-patient-use KwikPen within 45 days" of the last one.6

Tirzepatide is also sold compounded, by many of the same programs. The same FDA caveat applies.1

The Zepbound vs Wegovy guide goes through the two side by side, and the switching guide quotes what the labels say about moving from one to the other.

Ozempic: the same drug on a diabetes label

Ozempic is semaglutide too, made by Novo Nordisk. Its label reads "OZEMPIC is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus."8 For someone with type 2 diabetes whose plan covers Ozempic, that can be the cheapest route to semaglutide there is. For weight loss without diabetes, plans that refuse Wegovy generally will not pay for Ozempic either, and whether to prescribe it is your clinician's call.

Paying cash, Ozempic is not cheaper than Wegovy. NovoCare charges new self-pay patients $199 for each of the first two months, then $349 a month up to 1 mg and $499 for 2 mg.2 The Wegovy vs Ozempic guide covers the difference.

All six side by side

AlternativeMoleculeFDA-approved for weight lossFormWhat it costs
Compounded semaglutidesemaglutideNo, not FDA-approvedweekly injectionlive on the board above
Wegovy, NovoCaresemaglutideYesweekly injectionNovo's prices: $199 for two months for new patients, then $349
Wegovy pillsemaglutideYesdaily tabletNovo's prices: $149 to $299 by dose
FoundayoorforglipronYesdaily tabletLilly's price: from $149 at the lowest dose
Zepbound, Lilly self-paytirzepatideYesweekly injectionLilly's prices: $299 to $699 by dose; $449 KwikPen with on-time refills
Compounded tirzepatidetirzepatideNo, not FDA-approvedweekly injectionlive on the board above

Ozempic is left out of the table because it is not approved for weight loss; it belongs in the conversation only for people with type 2 diabetes.

Which one fits

  • You want the lowest monthly price and accept a compounded product: compounded semaglutide keeps you on the molecule you already know.
  • You want to stay on approved Wegovy for less: NovoCare self-pay, or the Wegovy pill, which costs less than the pen at every dose.
  • You want the best trial result: tirzepatide, as Zepbound from Lilly self-pay or compounded from the board.
  • You do not want injections: the Wegovy pill or Foundayo, both priced lowest at their starting doses.
  • You have type 2 diabetes and coverage: ask whether your plan covers Ozempic before paying cash for anything.

Switching between any of these is a prescribing decision with its own dose plan; follow your prescriber.

Sources8
  1. FDA, Compounding and the FDA: Questions and Answers read October 2026“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.” ↩
  2. NovoCare Pharmacy, Wegovy and Ozempic self-pay prices (pill and pen) read October 2026“Patients pay $149 for each month of 1.5 mg, $199 per month for 4 mg and $299 per month for 9 mg and 25 mg. ... Patients new to the Wegovy® Savings Offer and NovoCare® Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg. Offer is for 2 monthly fills through December 31, 2026, then $349 per month for Wegovy® 0.25 mg, 0.5 mg, 1 mg, 1.7 mg or 2.4 mg and $399 per month for Wegovy® HD (semaglutide) injection 7.2 mg. ... Patients new to the Ozempic® Savings Offer and NovoCare® Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg. Offer for 2 monthly fills through December 31, 2026 then $349 per month for Ozempic® 0.25 mg, 0.5 mg or 1 mg and $499 per month for Ozempic® 2 mg.” ↩
  3. Wegovy.com, the tablet read October 2026“Wegovy is the first FDA-approved semaglutide pill for weight loss.” ↩
  4. Aronne et al., Tirzepatide as Compared with Semaglutide for the Treatment of Obesity, N Engl J Med 2025 (SURMOUNT-5) read October 2026“A total of 751 participants underwent randomization. The least-squares mean percent change in weight at week 72 was -20.2% (95% confidence interval [CI], -21.4 to -19.1) with tirzepatide and -13.7% (95% CI, -14.9 to -12.6) with semaglutide (P<0.001).” ↩
  5. Lilly, Zepbound pricing information (list price and self-pay prices) read October 2026“in doses of 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg, with direct-to-patient pricing of $299, $399, $499, $699, $699 and $699 respectively.” ↩
  6. Lilly, Zepbound KwikPen purchase offer terms read October 2026“You will automatically receive the $449 purchase offer on your first purchase of the 7.5 mg, 10 mg, 12.5 mg, or 15 mg Zepbound single-patient-use KwikPen. To continue to be eligible for this purchase offer, you must complete your refill purchase of the Zepbound single-patient-use KwikPen within 45 days of the delivery/received date of your previous Zepbound single-patient-use KwikPen prescription fill.” ↩
  7. Eli Lilly, Foundayo FDA approval announcement (self-pay price and ATTAIN-1 result) read October 2026“In the ATTAIN-1 trial, individuals taking the highest dose of Foundayo and who stayed on treatment lost an average of 27.3 pounds (12.4%) compared to 2.2 pounds (0.9%) with placebo. ... Individuals opting for self-pay can access Foundayo starting at $149 per month for the lowest dose.” ↩
  8. Ozempic prescribing information (DailyMed), indications read October 2026“OZEMPIC is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.” ↩

Common questions

What is the cheapest alternative to Wegovy?

Compounded semaglutide, the same active ingredient as Wegovy made by a licensed compounding pharmacy and sold through telehealth programs. Our board ranks every partner program's current price, read from the seller's own page. It is not FDA-approved: FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.

Is there a cheaper FDA-approved alternative to Wegovy?

Yes. The Wegovy pill is $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg through NovoCare Pharmacy, less than the pen at every dose. Lilly's Foundayo pill starts at $149 a month at its lowest dose. The Wegovy pen itself is $199 a month for the first two fills for new NovoCare self-pay patients, then $349 a month up to 2.4 mg.

Is anything more effective than Wegovy?

In the head-to-head trial, tirzepatide was. In SURMOUNT-5, a 72-week trial of 751 adults with obesity, tirzepatide (Zepbound's molecule) reduced body weight by 20.2% and semaglutide (Wegovy's molecule) by 13.7%. Lilly sells Zepbound self-pay at $299 to $699 a month by dose, or $449 on the KwikPen from 7.5 mg with on-time refills.

Is Ozempic an alternative to Wegovy?

It is the same drug, semaglutide, from the same maker, but its label is for type 2 diabetes, not weight loss. For someone with type 2 diabetes whose plan covers Ozempic it can be the cheapest route to semaglutide. Paying cash it is not cheaper: NovoCare charges $349 a month up to 1 mg after the two-month starter offer, and $499 for 2 mg.

Is there a pill alternative to Wegovy?

Two. The Wegovy pill is oral semaglutide, $149 to $299 a month by dose through NovoCare Pharmacy. Foundayo is Lilly's orforglipron pill, from $149 a month at the lowest dose on self-pay. In Lilly's ATTAIN-1 trial, people on the highest Foundayo dose who stayed on treatment lost 12.4% of their body weight on average.

Choosing a program? See our ranking of the best online GLP-1 programs for every partner side by side, or the cheapest semaglutide page for price alone.

Read next